The effect of L-arginine supplementation on serum resistin concentration in insulin resistance in animal models

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 4, 2014, Pages 575-580

  Szulinska, M ^a   Musialik, K ^a   Suliburska, J ^b   Lis, I ^a   Bogdanski, P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Insulin resistance; L arginine; Rats; Resistin

Indexed keywords

ARGININE; GLUCOSE; INSULIN; NITRIC OXIDE; RESISTIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; RETN PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; NONHUMAN; OBESITY; RAT; WISTAR RAT; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; TIME;

ADIPOSITY; ANIMALS; ARGININE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; INSULIN; INSULIN RESISTANCE; MALE; NITRIC OXIDE; OBESITY; RATS, WISTAR; RESISTIN; TIME FACTORS;

EID: 84897008211     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. FLEGAL KM, CARROLL MD, OGDEN CL, CURTIN LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
2. WORLD HEALTH ORGANIZATION (WHO), World health statistics-2012, http://www.who.int.
3. POPKIN BM. Is the obesity epidemic a national security issue around the globe? Curr Opin Endocrinol Diabetes Obes 2011; 18: 328-331.
4. WU G, MORRIS SM. Arginine metabolism, nitric oxide and beyond. Biochem J 1998; 336: 1-17.
5. SULIBURSKA J, BOGDANSKI P, SZULINSKA M, PUPEK-MUSIALIK D, JABLECKA A. Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation. Eur J Nutr 2013, doi: 10.1007/s00394-013-0533-7.
6. BOGDA SKI P, SULIBURSKA J, GRABA SKA K, MUSIALIK K, CIESLEWICZ A, SKOLUDA A, JABLECKA A. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patient with visceral obesity. Eur Rev Med Pharmacol Sci 2012; 16: 816-823.
7. LU H, WANG H, WEN Y, ZHANG M, LIN H. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J Gastroenterol 2006; 12: 1747-1751.
8. BOKAREWA M, NAGAEV I, DAHLBERG L, SMITH U, TARKOWSKI A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-5795.
9. LEE H, LEE IS, CHOUE R. Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr 2013; 16: 143-152.
10. JENSEN MD, RYAN DH, APOVIAN CM, ARD JD, COMUZZIE AG, DONATO KA, HU FB, HUBBARD VS, JAKICIC JM, KUSHNER RF, LORIA CM, MILLEN BE, NONAS CA, PISUNYER FX, STEVENS J, STEVENS VJ, WADDEN TA, WOLFE BM, YANOVSKI SZ. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2013, doi: 10.1161/01.cir.0000437739.71477.ee.
11. FORD ES, MOKDAD AH. Epidemiology of obesity in the western hemisphere. J Clin Endocrinol Metab 2008; 93: 1-8.
12. HERNÁNDEZ VR, VILAHUR G, BADIMON L. Obesity with insulin resistance increase thrombosis in wildtype and bone marrow-transplanted Zucker fatty rats. Thromb Haemost 2013; 109: 319-327.
13. HERNÁNDEZ-DÍAZ G, ALEXANDER-AGUILERA A, ARZABAVILLALBA A et al. Effect of conjugated linoleic acid on body fat, tumor necrosis factor alpha and resistin secretion in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 105-109.
14. BLOOMGARDEN ZT. Cardiovascular complications of insulin resistance. Metab Syndr Relat Disord 2005; 3: 305-315.
15. ALZADJALI MA, GODFREY V, KHAN F, CHOY A, DONEY AS, WONG AK, PETRIE JR, STRUTHERS AD, LANG CC. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 2009; 53: 747-753.
16. KIM K, LEE K, MOON Y, SUL H. A cysteinerich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11252-11256.
17. LU H, WANG H, WEN Y, ZHANG M, LIN H. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J Gastroenterol 2006; 12: 1747-1751.
18. SHENG H, DI J, JIN Y. Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 2008; 2: 135-143.
19. MOHAMAD-SHAHI M, KARANDISH M, HAIDARI F, OMIDIAN K, FATEMI-TABATABAYEI SR, RAFIEI H. Effect of daidzeinlow-calorie diet on body weight, serum levels of glucose, resistin, and high sensitive C-reactive protein in high fat, high calorie diet induced rats. Saudi Med J 2012; 33: 70-75.
20. YANG Y, XIAO M, MAO Y, LI H, ZHAO S, GU Y, WANG R, YU J, ZHANG X, IRWIN DM, NIU G, TAN H. Resistin and insulin resistance in hepatocytes: resistin disturbs glycogen metabolism at the protein level. Biomed Pharmacother 2009; 63: 366-374.
21. LAU C, MUNIANDY S. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study. Cardiovasc Diabetol 2011; 10: 8.
22. SHENG H, DI J, JIN Y. Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 2008; 2: 135-143.
23. RABE K, LEHRKE M, PARHOFER K, BROEDL U. Adipokines and insulin resistance. Mol Med 2008; 14: 741-751.
24. LUCOTTI P, MONTI L, SETOLA E, LA CANNA G, CASTIGLIONI A, ROSSODIVITA A, PALA MG, FORMICA F, PAOLINI G, CATAPANO AL, BOSI E, ALFIERI O, PIATTI P. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass. Metabolism 2009; 58: 1270-1276.
25. LUCOTTI P, SETOLA E, MONTI LD, GALLUCCIO E, COSTA S, SANDOLI EP, FERMO I, RABAIOTTI G, GATTI R, PIATTI P. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 2006; 291: 906-912.
26. DE CASTRO BARBOSA T, LOURENÇO POYARES L, FABRES MACHADO U, NUNES MT. Chronic oral administration of arginine induces GH gene expression and insulin resistance. Life Sci 2006; 79: 1444-1449.
27. KAWANO T, NOMURA M, NISIKADO A, NAKAYA Y, ITO S. Supplementation of L-arginine improves hypertension and lipid metabolism but not insulin resistance in diabetic rats. Life Sci 2003; 73: 3017-3026.
28. JOBGEN WS, FRIED SK, FU WJ, MEININGER CJ, WU G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 2006; 17: 571-588.
29. BAKER DH. Advances in protein-amino acid nutrition of poultry. Amino Acids 2009; 37: 29-41.
30. BOGER RH, BODE-BOGER SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001; 41: 79-99.
31. FLU WJ, HAYNES TE, KOHLI R, HU J, SHI W, SPENCER TE, CARROLL RJ, MEININGER CJ, WU G. Dietary Larginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 2005; 135: 714-721.